Incidence and clinical profile of JAK2 V617F mutation in myelofibrosis with myeloid metaplasia.

被引：0
|
作者：
Barosi, G
Marchetti, M
Massa, M
Rosti, V
Vannucchi, A
Invernizzi, R
Campanelli, R
Viarengo, G
Magrini, U
Bergamaschi, G
机构：
[1] Policlin San Matteo, IRCCS, Lab Clin Epidemiol, I-27100 Pavia, Italy
[2] Policlin San Matteo, IRCCS, Biotechnol Lab, I-27100 Pavia, Italy
[3] Policlin San Matteo, IRCCS, Transplant Res Area, I-27100 Pavia, Italy
[4] Policlin San Matteo, IRCCS, Unit Clin Immunol, Immunohematol & Transfus Serv, I-27100 Pavia, Italy
[5] Policlin San Matteo, IRCCS, Dept Pathol, I-27100 Pavia, Italy
[6] Osped Careggi, Dept Hematol, Florence, Italy
[7] Policlin San Matteo, IRCCS, Unit Internal Med, I-27100 Pavia, Italy
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
256
引用
收藏
页码：78A / 78A
页数：1
相关论文
共 50 条
  • [1] Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia
    Fiorini, A.
    Reddiconto, G.
    Farina, G.
    Marietti, S.
    Palladino, M.
    Chiusolo, P.
    Leone, G.
    Sica, S.
    LEUKEMIA, 2006, 20 (12) : 2198 - 2199
  • [2] Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia
    Fiorini, A.
    Reddiconto, G.
    Farina, G.
    Marietti, S.
    Palladino, M.
    Giammarco, S.
    Chiusolo, P.
    Leone, G.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S298 - S298
  • [3] Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia
    A Fiorini
    G Reddiconto
    G Farina
    S Marietti
    M Palladino
    P Chiusolo
    G Leone
    S Sica
    Leukemia, 2006, 20 : 2198 - 2199
  • [4] V617F mutation in JAK2 is associated idiopathic myelofibrosis
    Campbell, PJ
    Griesshammer, M
    Döhner, K
    Döhner, H
    Kusec, R
    Hasselbalch, HC
    Larsen, TS
    Pallisgaard, N
    Giraudier, S
    Le Bousse-Kerdilès, MC
    Desterke, C
    Guerton, B
    Dupriez, B
    Bordessoule, D
    Fenaux, P
    Kiladjian, JJ
    Viallard, JF
    Brière, J
    Harrison, CN
    Green, AR
    Reilly, JT
    BLOOD, 2006, 107 (05) : 2098 - 2100
  • [5] The JAK2 V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: Clinical correlates and prognostic relevance in 157 patients.
    Tefferi, A
    Lasho, TL
    Schwager, SM
    Steensma, DP
    Mesa, RA
    Li, CY
    Wadleigh, M
    Gilliland, DG
    BLOOD, 2005, 106 (11) : 978A - 978A
  • [6] Prognostic relevance of JAK2 V617F mutation in primary myelofibrosis
    Barosi, G.
    Bergamaschi, G.
    Marchetti, M.
    Massa, M.
    Rosti, V.
    Bonetti, E.
    Vannucchi, A. M.
    Guglielmelli, P.
    Antonioli, E.
    Campanelli, R.
    Villani, L.
    Viarengo, G. L.
    Barbui, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 241 - 241
  • [7] Decreased JAK2 V617F allele burden level in a myelofibrosis with myeloid metaplasia patient with leukemic transformation
    Wu, Yi-Ying
    Hung, Hsiu-Man
    Chen, Tien-Sheng
    Chao, Tsu-Yi
    Ho, Ching-Liang
    LEUKEMIA RESEARCH, 2008, 32 (11) : 1783 - 1786
  • [8] Neutrophilia and the JAK2 V617F Mutation
    Langabeer, Stephen E.
    Haslam, Karl
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
  • [9] DOES ALLELE BURDEN IMPORT IN MYELOFIBROSIS WITH JAK2 V617F MUTATION?
    Maria Isabel, Montero Cuadrado
    Francisco Jose, Marquez Malaver
    Cruz Estrella, Carrillo
    Canale Silvia, Garcia
    Lucia, Mezquita
    Javier, Delgado
    Caro Rocio, Marin
    Francisco Jose, Martin Dominguez
    Nancy, Rodriguez
    Campos Jose, Gonzalez
    Jose Francisco, Falantes
    Jose Antonio, Perez Simon
    HAEMATOLOGICA, 2021, 106 (10) : 258 - 258
  • [10] Splenomegaly and the JAK2 V617F mutation
    Langabeer, Stephen E.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E45 - E46
12345